126 related articles for article (PubMed ID: 2538426)
1. Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type calcium channel. Evidence for a fourth site in the cardiac calcium entry blocker receptor complex.
King VF; Garcia ML; Shevell JL; Slaughter RS; Kaczorowski GJ
J Biol Chem; 1989 Apr; 264(10):5633-41. PubMed ID: 2538426
[TBL] [Abstract][Full Text] [Related]
2. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
[TBL] [Abstract][Full Text] [Related]
3. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
4. Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity.
Garcia ML; King VF; Shevell JL; Slaughter RS; Suarez-Kurtz G; Winquist RJ; Kaczorowski GJ
J Biol Chem; 1990 Mar; 265(7):3763-71. PubMed ID: 2154487
[TBL] [Abstract][Full Text] [Related]
5. Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac, and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade.
Qar J; Galizzi JP; Fosset M; Lazdunski M
Eur J Pharmacol; 1987 Sep; 141(2):261-8. PubMed ID: 2445589
[TBL] [Abstract][Full Text] [Related]
6. A novel high affinity class of Ca2+ channel blockers.
Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
[TBL] [Abstract][Full Text] [Related]
7. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
8. Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin.
King VF; Garcia ML; Himmel D; Reuben JP; Lam YK; Pan JX; Han GQ; Kaczorowski GJ
J Biol Chem; 1988 Feb; 263(5):2238-44. PubMed ID: 2448307
[TBL] [Abstract][Full Text] [Related]
9. Characterization of verapamil binding sites in cardiac membrane vesicles.
Garcia ML; Trumble MJ; Reuben JP; Kaczorowski GJ
J Biol Chem; 1984 Dec; 259(24):15013-6. PubMed ID: 6096353
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane.
Chatelain P; Dewinkeleer P; Beaufort P; Meysmans L; Clinet M
Eur J Pharmacol; 1994 Apr; 267(2):151-60. PubMed ID: 8050476
[TBL] [Abstract][Full Text] [Related]
11. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
Schmid A; Romey G; Barhanin J; Lazdunski M
Mol Pharmacol; 1989 Jun; 35(6):766-73. PubMed ID: 2543910
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors.
Galizzi JP; Fosset M; Romey G; Laduron P; Lazdunski M
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7513-7. PubMed ID: 2429309
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the slow calcium channel binding sites for [3H]SR 33557 in rat heart sarcolemmal membranes.
Chatelain P; Beaufort P; Meysmans L; Clinet M
Mol Pharmacol; 1991 Jan; 39(1):64-71. PubMed ID: 1846221
[TBL] [Abstract][Full Text] [Related]
14. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
Haase H; Wallukat G; Vetter R; Will H
Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the calcium entry blocker receptor complex in cardiac sarcolemmal membrane vesicles.
Kaczorowski GJ; Garcia ML; King VF
Prog Clin Biol Res; 1988; 252():29-34. PubMed ID: 2450371
[No Abstract] [Full Text] [Related]
16. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
[TBL] [Abstract][Full Text] [Related]
17. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
18. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.
Gould RJ; Murphy KM; Reynolds IJ; Snyder SH
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5122-5. PubMed ID: 6136040
[TBL] [Abstract][Full Text] [Related]
19. Separate binding and functional sites for omega-conotoxin and nitrendipine suggest two types of calcium channels in bovine chromaffin cells.
Ballesta JJ; Palmero M; Hidalgo MJ; Gutierrez LM; Reig JA; Viniegra S; Garcia AG
J Neurochem; 1989 Oct; 53(4):1050-6. PubMed ID: 2549193
[TBL] [Abstract][Full Text] [Related]
20. Effect of propionyl-L-carnitine on L-type calcium channels in human heart sarcolemma.
Bevilacqua M; Vago T; Norbiato G
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():31-5. PubMed ID: 1851633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
